Bimekizumab in Psoriasis: 3-Year Outcomes

• by Kathryn Wighton

• March 12, 2026

GLP-1 RAs May Ease Psoriasis, PsA Data Limited

Published evidence linked liraglutide and semaglutide to improvements in psoriasis severity, inflammatory markers, and metabolic outcomes, while evidence in psoriatic arthritis remained sparse.

• by Andrea Surnit

• June 27, 2026

• 4 min

The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics

• by Yue Zhang, Zhinan Shi, Xiaohui Mo, Qiang Ju, Zhanyan Pan

• July 1, 2026

Development and validation of a predictive nomogram for osteoporosis in patients with psoriasis

• by Zhilong Wang, Zhiyou Zhou, Ruichen Jiang, Haoning Ma, Yanzhu Shen, Xiangsheng Tang, Ping Yi, Yi Li, Zihan Wei

• July 10, 2026